Keurig Dr Pepper

Strengths: KDP has balanced reinvestment with dividends (2025 dividends declared $0.92 per share) and opportunistic M&A to build advantaged categories (e.g., 60 percent of GHOST with rights to the remainder in 2028; Nutrabolt/C4 stake and distribution).

The 2025–2026 financing stack for JDE Peet’s, including the pod‑manufacturing JV and convertible preferred, is creative and spreads risk across equity‑like capital. Trade‑offs: Share repurchases paused as leverage and deal financing took priority.

The GHOST mandatory redemption liability (~$880 million as of year‑end 2025) and the step‑up in corporate complexity (bridge and term financing, JV) elevate execution and governance demands. Overall record is good, but the bar for integration and separation is high.